1. |
Siegel R, Jemal A, Ma Jiemin, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
|
2. |
邓太海, 陈舒华. 转铁蛋白受体与肿瘤疾病的关系. 海南医学, 2011, 22(5): 137-140.
|
3. |
陈玥琦. 转铁蛋白受体与肿瘤疾病的关系. 实用肿瘤学杂志, 2015, 29(1): 65-68.
|
4. |
张洪明. 转铁蛋白受体的结构、表达及功能. 实用临床医药杂志, 2008, 12(5): 114-117.
|
5. |
Leplletier Y, Camara-Clayette V, Jin H, et al. Prevemion of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments. Cancer Res, 2007, 67(3): 1145-1154.
|
6. |
Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol, 2006, 121(2): 144-158.
|
7. |
Giannetti AM, Snow PM, Zak O, et al. Mechanism for multiple ligand recognition by the human transferring receptor. PLoS Biol, 2003, 1(3): E51.
|
8. |
陈舒华, 周少雄, 张继平, 等. 鼻咽癌高癌家系癌患者不同体质证型的蛋白质组学研究. 中国中西医结合耳鼻咽喉科杂志, 2013, 21(1): 5-9.
|
9. |
Panieri E. Breast cancer screening in developing countries. Best Pract Res Clin Obstet Gynaecol, 2012, 26(2): 283-290.
|
10. |
原永明, 周雪颖, 韩倩, 等. 肝癌患者血清铁含量检测的临床意义. 检验医学, 2013, 28(6): 534-535.
|
11. |
Theler JM. Bone tissue substitutes and replacements. Curr Opin Otolaryngol Head Neck Surg, 2011, 19(4): 317-321.
|
12. |
刘双林, 王志华, 胡志全, 等. 抗人转铁蛋白受体单克隆抗体增强姜黄素对雄激素非依赖性前列腺癌的抑制效应. 华中科技大学学报: 医学版, 2012, 41(3): 284-287, 295.
|
13. |
张莉, 徐维平, 陆杨, 等. 转铁蛋白-转铁蛋白受体在肿瘤主动靶向治疗中的应用. 中国药业, 2012, 5(21): 1-3.
|
14. |
Zhang MX, Gurnerov DR, Kaltashov IA. Indirect detection of protein-metal binding: interaction of serum transferrin with In3+ and Bi3+. J Am Soc Mass Spectrom, 2004, 15(11): 1658-1664.
|
15. |
王丛珠, 王登平, 郑佐娅. 转铁蛋白介导作用的应用进展. 放射免疫学杂志, 2003, 16(5): 304-306.
|
16. |
汪溪, 李建业, 夏春咸. 双氢青蒿素抗肿瘤作用研究进展. 海南医学, 2010, 21(13): 119-121.
|
17. |
Efferth T, Benakis A, Romero MR, et al. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med, 2004, 37(7): 998-1009.
|
18. |
Sadava D, Phillips T, Lin C, et al. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. Cancer Lett, 2002, 179(2): 151-156.
|